home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  CHI's MICROARRAY DATA ANALYSIS  
  September 21, 2001

Biotechnology

 
     
  Cambridge Healthtech Institute, New Hotel: Hilton Alexandria Mark Center, Alexandria, Virginia
New Dates: November 12-13, 2001


New Dates: November 12-13, 2001
Workshop, Mining for Gold: November 14, 2001

Microarrays have exploded in the field of biological research. In fact, over 80 percent of laboratories using microarrays expect to increase their utilization over the next year. However, with the "boom" of the technology also comes the need for careful navigation through interpretation of the data minefield. The facilitation of adoption of standards for microarray experimental annotation, data representation, and the introduction of standard experimental controls and data normalization is critical for the resulting "boom" to be either destructive or productive.


 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Scientific Advisors

Mr. Thomas J. Downey, Partek Incorporated
Dr. Nathan Goodman, 3rd Millennium, Inc.
Dr. Hrissi Samartzidou, Molecular Dynamics/Amersham Pharmacia Biotech

Speakers

Dr. Dhammika Amaratunga, The R.W. Johnson Pharmaceutical Research Institute
Dr. Tarif A. Awad, Affymetrix, Inc.
Dr. Alex Chenchik, BD Clontech Laboratories, Inc.
Dr. Gary A. Churchill, The Jackson Laboratory
Mr. Thomas J. Downey, Partek Incorporated
Dr. Sorin Draghici, Wayne State University
Dr. Mary E. Edgerton, Vanderbilt University Medical Center
Dr. Michael Elashoff, Gene Logic, Inc.
Dr. James T. Fleming, University of Tennessee
Mr. Jason Goncalves, Iobion Informatics
Dr. Steven R. Gullans, Harvard Institutes of Medicine
Dr. Priti Hegde, GlaxoSmithKline Pharmaceuticals
Dr. Thomas M. Houts, Molecular Dynamics
Dr. Reid M. Huber, DuPont Pharmaceuticals
Dr. Simon M. Lin, Duke University Medical Center
Dr. Robert Nadon, Imaging Research Inc.
Dr. Steven Perrin, Biogen, Inc.
Dr. Michael Reich, The Whitehead Institute
Dr. David Robbins, ViaLogy
Dr. Hrissi Samartzidou, Molecular Dynamics/Amersham Pharmacia Biotech
Dr. Ed Spitznagel, Washington University
Dr. Chris Stoeckert, University of Pennsylvania
Dr. Greg Tucker-Kellogg, Millennium Pharmaceuticals
Dr. Joseph White, The Institute for Genomic Research

 
Deadline for Abstracts: N/A
 
Registration: http://www.chidb.com/2001/mda/index.htm
E-mail: fvargus@healthtech.com
 
  Posted by:   Frederick Vargus  
Host: wks253.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.